Cellular Immunotherapy and the Lung
Open Access
Abstract
The new era of cellular immunotherapies has provided state-of-the-art and efficient strategies for the prevention and treatment of cancer and infectious diseases. Cellular immunotherapies are at the forefront of innovative medical care, including adoptive T cell therapies, cancer vaccines, NK cell therapies, and immune checkpoint inhibitors. The focus of this review is on cellular immunotherapies and their application in the lung, as respiratory diseases remain one of the main causes of death worldwide. The ongoing global pandemic has shed a new light on respiratory viruses, with a key area of concern being how to combat and control their infections. The focus of cellular immunotherapies has largely been on treating cancer and has had major successes in the past few years. However, recent preclinical and clinical studies using these immunotherapies for respiratory viral infections demonstrate promising potential. Therefore, in this review we explore the use of multiple cellular immunotherapies in treating viral respiratory infections, along with investigating several routes of administration with an emphasis on inhaled immunotherapies.Keywords
This publication has 150 references indexed in Scilit:
- Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and DevelopmentCPT: Pharmacometrics & Systems Pharmacology, 2013
- Magnetic core-shell nanoparticles for drug delivery by nebulizationJournal of Nanobiotechnology, 2013
- Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant DiseaseClinical Infectious Diseases, 2012
- Novel vaccine development strategies for inducing mucosal immunityExpert Review of Vaccines, 2012
- Aerosol drug delivery: developments in device design and clinical useThe Lancet, 2011
- Cell culture processes for monoclonal antibody productionmAbs, 2010
- Optimized Aerosol Delivery to a Mechanically Ventilated RodentJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2009
- Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopesBlood, 2009
- Adoptive immunotherapy for posttransplantation viral infectionsTransplantation and Cellular Therapy, 2004
- Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantationBone Marrow Transplantation, 2000